Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression

被引:26
作者
Appay, V [1 ]
Hansasuta, P
Sutton, J
Schrier, RD
Wong, JK
Furtado, M
Havlir, DV
Wolinsky, SM
McMichael, AJ
Richman, DD
Rowland-Jones, SL
Spinha, CA
机构
[1] John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
[3] VA San Diego Healthcare Syst, La Jolla, CA USA
[4] Northwestern Univ, Chicago, IL 60611 USA
关键词
cytotoxic T lymphocytes; CD4+; HIV-1; nef; anti-retroviral therapy; tetramers;
D O I
10.1097/00002030-200201250-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Design: Antiretroviral therapy (ART) currently represents the best way to avert the lethal consequences of chronic persistent HIV-1 infection. It leads to significant reductions of plasma viremia, often to undetectable levels, but it can also be linked with the reduction and disappearance of detectable HIV-specific CD8 T-cell responses. Results: Here we describe a group of patients in whom ongoing replication of HIV, particularly transcription of Nef mRNA species, was detected despite prolonged and clinically successful antiretroviral treatment. Modest, but significant, numbers of HIV-specific CD8 T cells and CD4 T-cell responses were found in these subjects, with the strongest responses directed towards Nef epitopes. Detailed phenotypic analysis of the HIV-specific CD8 cells demonstrated low perforin levels and persistent expression of CD27, a phenotype associated with incomplete differentiation of cytotoxic T lymphocytes (CTL). Conclusion: This immature CTL phenotype has been described previously in association with chronic HIV disease, but its continued persistence is surprising in the setting of prolonged viral suppression on therapy and the presence of HIV-specific CD4 cell activity. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 33 条
  • [21] Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
    Li, TS
    Tubiana, R
    Katlama, C
    Calvez, V
    Ait Mohand, H
    Autran, B
    [J]. LANCET, 1998, 351 (9117) : 1682 - 1686
  • [22] Cellular immune responses to HIV
    McMichael, AJ
    Rowland-Jones, SL
    [J]. NATURE, 2001, 410 (6831) : 980 - 987
  • [23] Early and persistent human immunodeficiency virus type 1 (HIV-l)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection
    Musey, LK
    Krieger, JN
    Hughes, JP
    Schacker, T
    Corey, L
    McElrath, MJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) : 278 - 284
  • [24] Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy
    Ogg, GS
    Jin, X
    Bonhoeffer, S
    Moss, P
    Nowak, MA
    Monard, S
    Segal, JP
    Cao, Y
    Rowland-Jones, SL
    Hurley, A
    Markowitz, M
    Ho, DD
    McMichael, AJ
    Nixon, DF
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (01) : 797 - 800
  • [25] Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes
    Oxenius, A
    Price, DA
    Easterbrook, PJ
    O'Callaghan, CA
    Kelleher, AD
    Whelan, JA
    Sontag, G
    Sewell, AK
    Phillips, RE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3382 - 3387
  • [26] Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
    Palella, FJ
    Delaney, KM
    Moorman, AC
    Loveless, MO
    Fuhrer, J
    Satten, GA
    Aschman, DJ
    Holmberg, SD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) : 853 - 860
  • [27] HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
    Pitcher, CJ
    Quittner, C
    Peterson, DM
    Connors, M
    Koup, RA
    Maino, VC
    Picker, LJ
    [J]. NATURE MEDICINE, 1999, 5 (05) : 518 - 525
  • [28] Immune control of HIV-1 after early treatment of acute infection
    Rosenberg, ES
    Altfeld, M
    Poon, SH
    Phillips, MN
    Wilkes, BM
    Eldridge, RL
    Robbins, GK
    D'Aquila, RT
    Goulder, PJR
    Walker, BD
    [J]. NATURE, 2000, 407 (6803) : 523 - 526
  • [29] Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry
    Suni, MA
    Picker, LJ
    Maino, VC
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 212 (01) : 89 - 98
  • [30] Waldrop SL, 1998, J IMMUNOL, V161, P5284